Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

Yamamura, T; Weinshenker, B; Yeaman, MR; De Seze, J; Patti, F; Lobo, P; Von Budingen, HC; Kou, XJ; Weber, K; Greenberg, B

Yamamura, T (通讯作者)，Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, 4 Chome 1-1 Ogawahigashicho, Kodaira, Tokyo 1878551, Japan.

MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022; 66 ():

Abstract

Background: This analysis evaluated long-term safety findings from the SAkuraSky and SAkuraStar studies with satralizumab in patients with neuromyelit......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索